Skip to content

Insider · CIK 0001822522

Douglas Joseph Hirsch

director

Files at GDRX (GoodRx Holdings, Inc.). First filing -, latest -.

Douglas Joseph Hirsch files SEC Form 4 as director at GDRX (GoodRx Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Douglas Joseph Hirsch has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 10 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 16, 2026GDRX
GoodRx Holdings, Inc.
AGrant or award
Class A Common Stock
+73,434$0.00$0320,936Jun 17, 2026
May 27, 2026GDRX
GoodRx Holdings, Inc.
AGrant or award
Class A Common Stock
+4,642$0.00$0247,502May 29, 2026
Jan 1, 2026GDRX
GoodRx Holdings, Inc.
AGrant or award
Class A Common Stock
+10,950$0.00$0242,860Jan 5, 2026
Oct 26, 2025GDRX
GoodRx Holdings, Inc.
MOption exercise
Class A Common Stock
+20,521--231,909Oct 27, 2025
Oct 26, 2025GDRX
GoodRx Holdings, Inc.
MOption exercise
Restricted Stock Unitderivative
-20,521$0.00$041,042Oct 27, 2025
Jun 3, 2025GDRX
GoodRx Holdings, Inc.
AGrant or award
Class A Common Stock
+57,050$0.00$0211,388Jun 4, 2025
Jan 1, 2025GDRX
GoodRx Holdings, Inc.
AGrant or award
Class A Common Stock
+6,392$0.00$0154,338Jan 3, 2025
Oct 26, 2024GDRX
GoodRx Holdings, Inc.
AGrant or award
Class A Common Stock
+797$0.00$0127,349Oct 28, 2024
Oct 26, 2024GDRX
GoodRx Holdings, Inc.
AGrant or award
Class A Common Stock
+20,597$0.00$0147,946Oct 28, 2024
Oct 26, 2024GDRX
GoodRx Holdings, Inc.
AGrant or award
Restricted Stock Unitderivative
+61,563$0.00$061,563Oct 28, 2024

Questions about Douglas Joseph Hirsch

Answered from the filings on this page, as of the latest one.

Is Douglas Joseph Hirsch buying or selling?

Douglas Joseph Hirsch has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Douglas Joseph Hirsch's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Douglas Joseph Hirsch has 0.

Where does Douglas Joseph Hirsch file Form 4?

Douglas Joseph Hirsch has filed Form 4 at GDRX (GoodRx Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Douglas Joseph Hirsch: insider trades and track record | InsiderTell